Early prediction of neoadjuvant treatment outcome in locally advanced breast cancer using parametric response mapping and radial heterogeneity from breast MRI-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early prediction of neoadjuvant treatment outcome in locally advanced breast cancer using parametric response mapping and radial heterogeneity from breast MRI

Published:2019-11-18 Issue:5 Volume:51 Page:1403-1411
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:J Magn Reson Imaging

Author:

Drisis Stylianos¹^ORCID,El Adoui Mohammed²^ORCID,Flamen Patrick³,Benjelloun Mohammed²,Dewind Roland⁴,Paesmans Mariane⁵,Ignatiadis Michail⁶,Bali Maria¹,Lemort Marc¹

Affiliation:

1. Radiology DepartmentInstitute Jules Bordet Brussels Belgium

2. Medical Imaging DepartmentPolytechnic University of Mons Mons Belgium

3. Nuclear DepartmentInstitute Jules Bordet Brussels Belgium

4. Pathology DepartmentInstitute Jules Bordet Brussels Belgium

5. Statistics DepartmentInstitute Jules Bordet Brussels Belgium

6. Oncology DepartmentInstitute Jules Bordet Brussels Belgium

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmri.26996

Reference36 articles.

1. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

2. Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

3. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate;Goldie JH;Cancer Treat Rep,1979

4. The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27

5. Randomized Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With Cyclophosphamide, Methotrexate, and Fluorouracil in Premenopausal Women With Node-Positive Breast Cancer: Update of National Cancer Institute of Canada Clinical Trials Group Trial MA5

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation and predictive value of pathological complete response and ultrasound characteristic parameters in neoadjuvant chemotherapy for breast;World Journal of Clinical Cases;2024-08-16

2. Exploring Neoadjuvant Chemotherapy, Predictive Models, Radiomic, and Pathological Markers in Breast Cancer: A Comprehensive Review;Cancers;2023-11-04

3. Kinetic Heterogeneity Improves the Specificity of Dynamic Enhanced MRI in Differentiating Benign and Malignant Breast Tumours;Academic Radiology;2023-11

4. New Explainable Deep CNN Design for Classifying Breast Tumor Response Over Neoadjuvant Chemotherapy;Current Medical Imaging Formerly Current Medical Imaging Reviews;2023-04

5. Development and validation of a four-dimensional registration technique for DCE breast MRI;Insights into Imaging;2023-01-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3